eHealth (NASDAQ:EHTH) reported first-quarter 2026 results that management said came in ahead of internal expectations, citing stronger-than-anticipated Medicare enrollment volume and improved unit economics. On the company’s earnings call, Chief Executive Officer Derrick Duke said the quarter also reflected progress on strategic initiatives including targeted cost reductions and launch preparations for a new “lifetime advisory model” and a final expense insurance product introduced in April.
First-quarter results and profitability metrics
For the first quarter, eHealth reported total revenue of $88 million. GAAP net loss was $4.7 million and adjusted EBITDA was $9 million, which Duke said exceeded the company’s internal plan. Chief Financial Officer John Dolan added that the company “beat our revenue, earnings, and operating cash flow expectations and achieve[d] a greater Medicare enrollment profitability compared to a year ago.”
- Medicare Advantage (MA) lifetime value (LTV): up 3% year over year
- Medicare Supplement LTV: up 19%
- Prescription Drug Plan (PDP) LTV: up 78%
Dolan said Medicare enrollment profitability improved, with the Medicare LTV-to-CAC ratio at 1.4x versus 1.2x a year ago, a 17% improvement. Total acquisition costs per MA equivalent approved member declined 10%, driven by a 28% reduction in variable marketing costs per MA equivalent approved member, partially offset by a 9% increase in customer care and enrollment costs per MA equivalent approved member.
The higher customer care and enrollment costs reflected lower application volume and “our decision to retain sufficient agent capacity to support the launch of our lifetime advisory model,” Dolan said. He also noted the company plans for a telesales organization with a higher mix of tenured advisors, which management expects will benefit conversions and enrollment quality.
Medicare segment gross profit was $33 million, down 8% year over year, but gross margin increased to 41% from 34%, reflecting the improved LTV-to-CAC ratio. In the Employer and Individual segment, revenue was $6.7 million versus $9.5 million a year ago, and gross profit was $3.7 million compared with $6.0 million last year.
Tail revenue and non-commission revenue trends
eHealth recognized $8 million of positive net adjustment revenue, or “tail revenue,” compared with $10.5 million in the prior-year quarter. Dolan said tail revenue represents cash collections above original lifetime value estimates and was driven by Medicare and ancillary products. He also said the company “continue[s] to hold significant unrecognized positive adjustments related to our existing book of business.”
During Q&A, Dolan said eHealth’s long-range plan assumes “effectively flat tail revenue growth,” consistent with assumptions in 2026 guidance and the out years. He emphasized that projected revenue growth in 2027 and 2028 is “not coming from increased tail,” but instead from other revenue streams.
Non-commission revenue in the quarter was $8.2 million, which Dolan said was ahead of internal expectations and reflected lower carrier sponsorship revenue compared with a year ago.
Cost reductions and operating model changes
Management highlighted actions to reduce fixed costs and focus spending on higher-performing channels. Duke said eHealth implemented headcount reductions and vendor consolidation initiatives expected to reduce fixed operating costs by approximately $30 million in 2026 compared with 2025, representing roughly a 20% reduction. He said the company began to realize some savings in the first quarter, with the full impact expected to become more evident later in the year.
Dolan said first-quarter non-GAAP total operating expenses (excluding stock-based compensation and restructuring) declined 21% to $82.3 million. He detailed reductions across key expense lines, including non-GAAP marketing and advertising expense down 38% (including a 44% reduction in variable marketing), non-GAAP customer care and enrollment expense down 13%, non-GAAP technology and content expense down 8%, and non-GAAP general and administrative expense down 6%.
GAAP net results were also affected by restructuring. Dolan said the year-over-year decline from GAAP net income of $2.0 million to a GAAP net loss of $4.7 million was “primarily driven by restructuring charges related to our headcount reduction this quarter.”
Lifetime advisory model and diversification initiatives
Duke described the lifetime advisory model as a strategic shift aimed at fostering “deeper, longer-lasting relationships between members and advisors,” positioning eHealth as “a trusted ally throughout their healthcare journey” rather than a one-time enrollment platform. He said the model is supported by new agent-facing technology tools, including a customer dashboard, system-generated engagement prompts, and “dynamic insight-driven scripts embedded directly into the sales and service workflow.”
As part of broader diversification efforts, Duke said eHealth is expanding services beyond core Medicare Advantage, noting existing ancillary offerings such as dental, vision, hearing, and hospital indemnity plans. He said the company launched final expense insurance last month, describing it as offering “attractive unit economics and a compelling cash flow profile.”
In response to analyst questions about how the model changes engagement, Duke said the new approach differs from prior efforts where new products required separate advisors and incremental marketing budgets. Under the lifetime advisory model, he said, cross-selling does not rely on “additional marketing spend” or “additional agents,” but instead equips existing advisors to develop a “holistic relationship” with members.
Michelle (who joined management’s response during Q&A) said the model is designed to “put the consumer first” and increase ongoing engagement through activities such as plan check-ins, helping members connect with a primary care physician, supporting annual wellness visits, generating referrals, and incorporating cross-sell opportunities into the relationship.
Asked about unit economics for ancillary cross-sell, Duke said management views each ancillary product as having its own LTV profile, but suggested that “for each cross-sell opportunity…we have the opportunity to add somewhere between maybe 15%-20% of LTV to the MA sale when we sell an ancillary plan.” On ICHRA-related economics, Duke said it was “a little early” to share unit economics and that ICHRA is “certainly not material” to the 2028 revenue growth plan at this point, though some ancillary products carry “a much more favorable cash flow profile.”
Cash flow, balance sheet, and outlook
First-quarter operating cash flow was $35.8 million compared with $77.1 million in the prior-year quarter, but Dolan said it was ahead of internal expectations and that the company remains on track for its full-year operating cash flow goals. He attributed most of the year-over-year decline to timing and one-time items, including severance related to fixed cost reductions, lower commission collections due to reduced volume, and lower carrier sponsorship revenue that benefited the prior-year quarter.
At the end of March 2026, eHealth reported $110.8 million in cash equivalents and short-term marketable securities. Dolan said the company is maintaining its 2026 guidance ranges for revenue, GAAP net income, adjusted EBITDA, and operating cash flow, while updating its outlook for 2026 net adjustment revenue to a range of $8 million to $20 million.
Looking beyond 2026, Duke said the company’s revised three-year outlook reflects a return to revenue growth in 2027 alongside adjusted EBITDA margin expansion and improving cash flow. He characterized 2026 as an “intentional bridge year,” where eHealth is prioritizing operating cash flow over volume by focusing on the most profitable channels, building the lifetime advisory model, and pursuing diversification initiatives with discipline. Dolan added that the company’s three-year forecast assumes a modest increase in Medicare marketing spending in best-performing channels beginning in the fourth quarter of 2027, with growth supported by cross-selling ancillary products and an expected contribution from ICHRA beginning in 2028.
Management also discussed the external Medicare environment. Duke noted that CMS finalized a 2027 Medicare Advantage rate “above the initial proposal,” which he called an encouraging signal, while adding that the company remains early in the annual enrollment period planning cycle and expects carrier inventory dynamics to remain complex amid continued Medicare Advantage “reset cycle” adjustments.
About eHealth (NASDAQ:EHTH)
eHealth, Inc operates one of the largest online private health insurance exchanges in the United States. The company’s platform enables consumers to compare, select and enroll in individual, family and small-group health insurance plans offered by a broad network of licensed insurance carriers. In addition to Affordable Care Act–compliant offerings, eHealth provides dedicated services for Medicare Advantage, Medicare Supplement and Medicare Part D prescription drug plans, helping seniors navigate the complexities of Medicare coverage.
Through its digital marketplace, eHealth delivers real-time quotes, detailed plan comparisons and enrollment processing.
